Verona Pharma (VRP)

All online trades £12.50 plus an annual Management Fee of £35 & VAT with Selftrade. Apply

 3.88p
   
  • Change Today:
      0.000p
  • 52 Week High: 11.00
  • 52 Week Low: 3.79
  • Currency: UK Pounds
  • Shares Issued: 307.20m
  • Volume: 77,608
  • Market Cap: £11.90m
  • RiskGrade: 184
  • Beta: 0.73

Latest ShareCast News

Small caps round-up: Verona Pharma, PHSC, Sterling Green

Date: Friday 26 Nov 2010

Verona Pharma, respiratory diseases treatment developer, is initiating a new higher dose trial of its lead drug, RPL554, in patients with asthma, after receiving the go-ahead from the Dutch authorities.

Verona Pharma ShareCast News

Cash burn remains low at Verona 04-Sep-2009 ShareCast

Verona Pharma Regulatory News

Posting of Annual Report 08-May-2012 16:56 PR Newswire
Verona Pharma appoints new CEO 01-May-2012 07:00 PR Newswire
Verona Pharma - Preliminary Unaudited Results 05-Apr-2012 07:00 PR Newswire
Verona Pharma – First UK RPL554 anti-inflammat... 09-Mar-2012 07:00 PR Newswire
Total Voting Rights 31-Jan-2012 07:00 PR Newswire

Verona Pharma Newspaper Links

Cracking hack bid 14-Nov-2007 Sun

Verona Pharma Tips & Analysis

Market Report: Barclays buoyed by Bank of Americ... 05-Oct-2007 The Independent
Small caps 05-Oct-2007 Times

Verona Pharma News Wires

No recent information was found.

Other Verona Pharma News

FTSE in-depth: Recovery fears spook investors 29-Oct-2009 This Is Money
Yesterday's trading: Chloride sizzles on buyout ... 29-Jan-2009 This Is Money
Yesterday's trading: Verona's cure 20-May-2008 This Is Money
Verona Pharma to test asthma treatment 02-Mar-2008 This Is Money
Yesterday's trading: BP boss battles the tide 27-Feb-2008 This Is Money

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Verona Pharma Market Data

Currency UK Pounds
Share Price 3.88p
Change Today 0.000p
% Change 0.00 %
52 Week High 11.00
52 Week Low 3.79
Volume 77,608
Shares Issued 307.20m
Market Cap £11.90m
Beta 0.73
RiskGrade 184

Verona Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
38.61% below the market average38.61% below the market average38.61% below the market average38.61% below the market average38.61% below the market average
2.13% below the sector average2.13% below the sector average2.13% below the sector average2.13% below the sector average2.13% below the sector average
Price Trend
87.72% below the market average87.72% below the market average87.72% below the market average87.72% below the market average87.72% below the market average
96.43% below the sector average96.43% below the sector average96.43% below the sector average96.43% below the sector average96.43% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Verona Pharma Dividends

No dividends found

Trades for 25-May-2012

Time Volume / Share Price
14:09 823 @ 3.79p
08:01 76,785 @ 3.99p

Verona Pharma Key Personnel

Chair Clive Page
CEO Michael Walker

Top of Page